Hobbs Group Advisors LLC Has $412,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Hobbs Group Advisors LLC raised its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 8.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 705 shares of the healthcare conglomerate’s stock after buying an additional 57 shares during the quarter. Hobbs Group Advisors LLC’s holdings in UnitedHealth Group were worth $412,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Cornerstone Wealth Management LLC grew its holdings in shares of UnitedHealth Group by 5.3% in the 2nd quarter. Cornerstone Wealth Management LLC now owns 1,964 shares of the healthcare conglomerate’s stock valued at $1,000,000 after buying an additional 98 shares during the period. Redhawk Wealth Advisors Inc. acquired a new stake in shares of UnitedHealth Group during the second quarter worth about $546,000. James J. Burns & Company LLC acquired a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $1,773,000. Meadow Creek Wealth Advisors LLC lifted its stake in UnitedHealth Group by 6.4% in the second quarter. Meadow Creek Wealth Advisors LLC now owns 2,355 shares of the healthcare conglomerate’s stock valued at $1,199,000 after buying an additional 141 shares in the last quarter. Finally, Patrick M Sweeney & Associates Inc. increased its position in shares of UnitedHealth Group by 4.9% during the second quarter. Patrick M Sweeney & Associates Inc. now owns 1,991 shares of the healthcare conglomerate’s stock worth $1,007,000 after acquiring an additional 93 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Up 0.8 %

Shares of UNH opened at $565.39 on Wednesday. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The firm has a market cap of $520.31 billion, a P/E ratio of 36.83, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The firm’s 50-day simple moving average is $586.36 and its 200 day simple moving average is $559.39.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. The firm had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $6.56 EPS. On average, analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.49%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Barclays raised their price objective on shares of UnitedHealth Group from $603.00 to $655.00 and gave the stock an “overweight” rating in a report on Wednesday, November 27th. Bank of America dropped their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. Hsbc Global Res lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Thursday, October 17th. UBS Group decreased their target price on shares of UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a research report on Wednesday, October 16th. Finally, Oppenheimer raised their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research report on Friday, December 6th. Three investment analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $626.84.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.